TY - JOUR
T1 - Plasma extracellular vesicle test sample to standardize flow cytometry measurements
AU - Bettin, Britta
AU - van der Pol, Edwin
AU - Nieuwland, Rienk
N1 - Funding Information: The authors thank C.M. Hau and N. Hajji for their excellent technical support. B.B. acknowledges funding for project 18HLT01: METVES II, which has received funding from the EMPIR program cofinanced by the participating states and from the European Union's Horizon 2020 Research and Innovation Program. E.v.d.P. acknowledges funding for VIDI project 19724 funded by the Dutch Research Council. Conceptualization: B.B. E.v.d.P. and R.N.; data curation: B.B.; formal analysis: B.B.; funding acquisition: E.v.d.P. and R.N.; investigation: B.B.; project administration: B.B. E.v.d.P. and R.N.; resources: E.v.d.P. and R.N.; visualization: B.B. and E.v.d.P.; writing—original draft: B.B. E.v.d.P. and R.N.; writing—review and editing: B.B. E.v.d.P. and R.N. E.v.d.P. is a cofounder and shareholder of the company Exometry B.V. (Amsterdam, The Netherlands). B.B. and R.N. declare no conflicts of interest. Funding Information: B.B. acknowledges funding for project 18HLT01: METVES II, which has received funding from the EMPIR program cofinanced by the participating states and from the European Union’s Horizon 2020 Research and Innovation Program. E.v.d.P. acknowledges funding for VIDI project 19724 funded by the Dutch Research Council. Publisher Copyright: © 2023 The Author(s)
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Background: Extracellular vesicles (EVs) in body fluids are explored as disease biomarkers, but EV concentrations measured by flow cytometers (FCMs) are incomparable. Objectives: To improve data comparability, new reference materials with physical properties resembling EVs and reference procedures are being developed. The validation of new reference materials and procedures requires biological test samples. We developed a human plasma EV test sample (PEVTES) that i) resembles subcellular particles in plasma, ii) is ready-to-use, iii) is flow cytometry–compatible, and iv) is stable. Methods: The PEVTES was prepared from human plasma of 3 fasting donors. EVs were immunofluorescently stained with antibodies against platelet-specific (CD61) and erythrocyte-specific (CD235a) antigens or lactadherin. To reduce the concentration of soluble proteins, lipoproteins, and unbound reagents, stained EVs were isolated from plasma by size-exclusion chromatography. After isolation, the PEVTES was filtered to remove remnant platelets. PEVTESs were diluted in cryopreservation agents, dimethyl sulfoxide, glycerol, or trehalose and stored at −80 °C for 12 months. After thawing, stained EV concentrations were measured with a calibrated FCM (Apogee A60-Micro). Results: We demonstrate that the developed PEVTES resembles subcellular particles in human plasma when measured using FCM and that the concentrations of prestained platelet-derived, erythrocyte-derived, and lactadherin+ EVs in the PEVTES are stable during storage at −80 °C for 12 months when stored in trehalose. Conclusion: The PEVTES i) resembles subcellular particles in plasma, ii) is ready-to-use, iii) is flow cytometry–compatible, and iv) is stable. Therefore, the developed PEVTES is an ideal candidate to validate newly developed reference materials and procedures.
AB - Background: Extracellular vesicles (EVs) in body fluids are explored as disease biomarkers, but EV concentrations measured by flow cytometers (FCMs) are incomparable. Objectives: To improve data comparability, new reference materials with physical properties resembling EVs and reference procedures are being developed. The validation of new reference materials and procedures requires biological test samples. We developed a human plasma EV test sample (PEVTES) that i) resembles subcellular particles in plasma, ii) is ready-to-use, iii) is flow cytometry–compatible, and iv) is stable. Methods: The PEVTES was prepared from human plasma of 3 fasting donors. EVs were immunofluorescently stained with antibodies against platelet-specific (CD61) and erythrocyte-specific (CD235a) antigens or lactadherin. To reduce the concentration of soluble proteins, lipoproteins, and unbound reagents, stained EVs were isolated from plasma by size-exclusion chromatography. After isolation, the PEVTES was filtered to remove remnant platelets. PEVTESs were diluted in cryopreservation agents, dimethyl sulfoxide, glycerol, or trehalose and stored at −80 °C for 12 months. After thawing, stained EV concentrations were measured with a calibrated FCM (Apogee A60-Micro). Results: We demonstrate that the developed PEVTES resembles subcellular particles in human plasma when measured using FCM and that the concentrations of prestained platelet-derived, erythrocyte-derived, and lactadherin+ EVs in the PEVTES are stable during storage at −80 °C for 12 months when stored in trehalose. Conclusion: The PEVTES i) resembles subcellular particles in plasma, ii) is ready-to-use, iii) is flow cytometry–compatible, and iv) is stable. Therefore, the developed PEVTES is an ideal candidate to validate newly developed reference materials and procedures.
KW - blood plasma
KW - calibration
KW - extracellular vesicles
KW - flow cytometry
KW - quality control
KW - standardization
UR - http://www.scopus.com/inward/record.url?scp=85165291852&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.rpth.2023.100181
DO - https://doi.org/10.1016/j.rpth.2023.100181
M3 - Article
C2 - 37538497
SN - 2475-0379
VL - 7
JO - Research and practice in thrombosis and haemostasis
JF - Research and practice in thrombosis and haemostasis
IS - 4
M1 - 100181
ER -